Diagnamed Holdings Corp. Stock Price

CNSX:DMED Community·CA$8.3m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

DMED Share Price Performance

CA$0.07

0.05 (250.00%)

CA$0.07

0.05 (250.00%)

CA$0.07

Tue, 28 Oct 25

Share PriceCA$0.07

DMED Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Medium-low risk with worrying balance sheet.

6 Risks

0 Rewards

View Full Analysis

Diagnamed Holdings Corp. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.01
: 0%
: 0%
: 0%

View Full Analysis

About DMED

Founded: n/a
Employees: n/a
CEO: John Karagiannidis
WebsiteView website: www.diagnamed.com

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.